These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38135521)

  • 1. Using Human-Centered Design to Explore Potential Users' and Men's Views of New Injectable Contraceptives in Kampala and Lagos.
    Burke HM; Callahan RL; Lawton A; Turinayo A; Oyekenu O; Niyonsaba S; Taiwo O; Semaganda VM; Awiti A; Fratus A; Mubiru F; OlaOlorun FM
    Glob Health Sci Pract; 2023 Dec; 11(6):. PubMed ID: 38135521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Service Delivery Considerations for Introducing New Injectable Contraceptives Lasting 4 and 6 Months in Nigeria and Uganda: A Qualitative Study.
    Callahan RL; Burke HM; Lawton A; OlaOlorun FM; Mubiru F; Anyasi H; Wong CM; Bidashimwa D; Velarde M; Ruderman LW
    Glob Health Sci Pract; 2023 Dec; 11(6):. PubMed ID: 38135518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Men can take part": examining men's role in supporting self-injectable contraception in southern Malawi, a qualitative exploration.
    Ruderman LW; Packer C; Zingani A; Moses P; Burke HM
    Reprod Health; 2022 Aug; 19(1):174. PubMed ID: 35945601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for a potential longer-acting injectable contraceptive: perspectives from women, providers, and policy makers in Kenya and Rwanda.
    Tolley EE; McKenna K; Mackenzie C; Ngabo F; Munyambanza E; Arcara J; Rademacher KH; Lendvay A
    Glob Health Sci Pract; 2014 May; 2(2):182-94. PubMed ID: 25276576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-month injectables are popular choice in Mexico.
    Netw Res Triangle Park N C; 1984; 5(3):4-5. PubMed ID: 12279798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to male involvement in contraceptive uptake and reproductive health services: a qualitative study of men and women's perceptions in two rural districts in Uganda.
    Kabagenyi A; Jennings L; Reid A; Nalwadda G; Ntozi J; Atuyambe L
    Reprod Health; 2014 Mar; 11(1):21. PubMed ID: 24597502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of injectable hormonal contraceptives: diverging perspectives of women and men, service providers and policymakers in Uganda.
    Hyttel M; Rasanathan JJ; Tellier M; Taremwa W
    Reprod Health Matters; 2012 Dec; 20(40):148-57. PubMed ID: 23245420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda.
    McKenna K; Arcara J; Rademacher KH; Mackenzie C; Ngabo F; Munyambanza E; Wesson J; Tolley EE
    Glob Health Sci Pract; 2014 Oct; 2(4):459-71. PubMed ID: 25611479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
    Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
    Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
    Dorflinger LJ
    Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
    Hassan EO; el-Nahal N; el-Hussein M
    Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors facilitating the use of contraceptive methods among urban adolescents and youth in Guinea: a qualitative study.
    Manet H; Doucet MH; Bangoura C; Dioubaté N; El Ayadi AM; Sidibé S; Millimouno TM; Delamou A
    Reprod Health; 2023 Jun; 20(1):89. PubMed ID: 37312141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning for Outcomes (P
    Lebetkin E; Gao X; Taylor D; Maldonado LY; Saad A; Steiner MJ; Dorflinger LJ; Nanda K; Mastro TD
    Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of "once-a-month" combined injectable contraceptives.
    Newton JR; D'arcangues C; Hall PE
    J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with men's participation in postpartum family planning: a study of Kiswa Health Centre III, Kampala, Uganda.
    Omona K; Mahoro RM
    J Obstet Gynaecol; 2023 Dec; 43(1):2158321. PubMed ID: 36606701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.